US Patent Issued to UNIVERSIDADE DE SANTIAGO DE COMPOSTELA on Nov. 11 for "Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of L-DOPA-induced dyskinesia" (Spanish Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,613, issued on Nov. 11, was assigned to UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, Spain).

"Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of L-DOPA-induced dyskinesia" was invented by Ana M. Munoz Patino (Santiago de Compostela, Spain), Jose Luis Labandeira Garcia (Santiago de Compostela, Spain) and Andrea Lopez Lopez (Santiago de Compostela, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of dyskinesias induced by L-DOPA. The present invention relates to the pharmaceutical field, more particularly to th...